UCSB Arts & Lectures and the Cancer Foundation of Santa Barbara host the Nobel Prize–winning biochemist for a talk on CRISPR ...

In a report released yesterday, Terence Flynn from Morgan Stanley maintained a Hold rating on Editas Medicine (EDIT – Research Report), ...

The technology’s promise can sound like science fiction—it might help us adapt to a radically different climate, or grow ...

CRISPR co-creator Jennifer Doudna on watching her groundbreaking gene-editing technology help sickle cell patients: “It’s extraordinary.” Jennifer Doudna codeveloped the revolutionary gene ...

In this conversation, Doudna breaks down what's next in gene-editing therapy and what's needed to ensure it's accessible to everyone.

Co-hosted by UC Santa Barbara Arts & Lectures and the Cancer Foundation of Santa Barbara, the talk will discuss CRISPR-Cas9 ...

The request to withdraw the pair of European patents, by lawyers for Nobelists Emmanuelle Charpentier and Jennifer Doudna ... These companies include Editas Medicine, allied with the Broad ...

When biochemist Jennifer Doudna and her research partner, Emmanuelle Charpentier, published a paper in Science 12 years ago, ...

Editas Medicine, Inc. engages in the development ... The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and ...

Jennifer Doudna, one of the coinventors of CRISPR technology, discusses how her work on bacterial defenses against viruses helped lead to a discovery with a revolutionary impact on biological research ...

Jennifer Doudna shared the 2020 Nobel Prize in Chemistry for her pioneering work in CRISPR gene editing. A look through a historic microscope helps explain what we all owe the Nobel Prize-winning ...